Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
Stock
EXEL
EXEL News & Events
-
Add to Watchlist
Trade EXEL
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
EXEL News
Exelixis Aims to Expand Beyond Cabozantinib Franchise
Feb 28 2026
NASDAQ.COM
Exelixis Aims to Become a Top Oncology Player with Expanding Pipeline
Feb 28 2026
Fool
Global Oncology Market Expected to Reach $748.17 Billion
Feb 24 2026
PRnewswire
Global Oncology Market Expected to Reach $748.17 Billion
Feb 24 2026
Newsfilter
Exelixis Growth Potential Analysis
Feb 20 2026
Fool
Exelixis Posts Strong Earnings—Could New Highs Be on the Horizon?
Feb 12 2026
Marketbeat
Exelixis Q4 2025 Earnings Call Highlights
Feb 11 2026
seekingalpha
EXELIXIS Q4 ADJUSTED EPS REACHES USD 0.94, BEATING IBES ESTIMATE OF USD 0.79
Feb 10 2026
moomoo
Show More News
EXEL Events
No data
EXEL Monitor News
Exelixis Reports Revenue Growth Amid Market Challenges
Mar 02 2026
Exelixis Inc reaches 20-day high amid market strength
Dec 22 2025
Exelixis Inc experiences decline amid market downturn.
Dec 08 2025
EXEL Earnings Analysis
Exelixis Earnings Surge on Drug Success & Growth- Intellectia AI™
4 months ago
Robust Growth Amid Strategic Developments - Intellectia AI™
1 years ago
People Also Watch
